Syngenta Shares Outperform as Goldman Added to 'Conviction Buy' List
Goldman believes recent concerns over the delayed U.S. crop planting season are overdone, while Syngenta's long-term fundamentals are sound.
The firm believes Syngenta's unlevered balance sheet could allow for over $4 billion in potential acquisitions. These acquisitions could generate substantial shareholder value and help "decouple" the company from the volatile agricultural cycle.
Latest Ratings for SYT
|Jul 2014||Credit Suisse||Upgrades||Neutral||Outperform|
|Apr 2014||Miller Tabak||Downgrades||Buy||Neutral|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.